Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App




Mindray Launches High Throughput BS-600M Chemistry Analyzer with Industry-Leading Small Footprint

By LabMedica International staff writers
Posted on 16 May 2022

Mindray (Shenzhen, China) has launched the new BS-600M, a powerful yet efficient chemistry analyzer designed to empower medium-volume laboratories with increased productivity, efficiency and reliability. More...

With a compact footprint of only 1.2 square meters and a throughput of 600 T/H (up to 800 T/H with ISE), the BS-600M chemistry analyzer has among the highest levels of throughput per square meter. It maximizes productivity for laboratories in a minimum amount of space. BS-600M allows continuous sample loading by racks and flexible STAT priority, which enables higher efficiency and prolonged walk-away time. Having high Sigma metric performance, it can help laboratories deliver high levels of testing quality, reduce QC measurements, simplify QC rules, and shorten turn-around time. These advantages enable significant reductions in troubleshooting work and consumption of QCs and reagents.

BS-600M features on-board hemolysis with whole blood for HbA1c tests. This eliminates the need for manual pretreatment, improving testing efficiency and reducing biohazardous risks and human errors. Mindray’s HbA1c assay on BS-600M can achieve excellent accuracy and precision. The enzymatic HbA1c method can also effectively prevent interferences from Hb variants and ensure no interference from other Hb derivatives. This means that reliable results can be obtained at the first measurement, without requiring further confirmations. Additionally, BS-600M requires much reduced reaction volumes for HbA1c tests, which contributes to around 30% lower cost per test. BS-600M also integrates a brand-new ISE solution, which reduces both the frequency of electrode replacement and the consumption of ISE reagents. As the result, the cost per test for ISE is reduced by around 35%. Moreover, ISE tests on BS-600M exhibit top levels of accuracy and precision in the field of ISE detection.

BS-600M also incorporates several other powerful functions, including intelligent detection, alarming and auto-rerun of abnormal reactions, fast input of QC & CAL target values via barcode scanning, a user-friendly operation interface, and breathing LEDs that indicate the status of the analyzer. All these powerful functions allow BS-600M to help medium-sized laboratories maximize their working efficiency and cost efficiency, and provide an amazing user experience for laboratory technicians. The performance advantages of BS-600M allow it to offer highly reliable results at reduced costs and to enhance clinician confidence and satisfaction.

Related Links:
Mindray 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.